-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Syndax Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2024.
- Syndax Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.17 M, a 12.4% decline year-over-year.
- Syndax Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $264 M, a 53.3% increase from 2022.
- Syndax Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $172 M, a 45.4% increase from 2021.
- Syndax Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $118 M, a 61.1% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)